Seeking Alpha

Amarin (AMRN +1.2%) says the USPTO has granted a Notice of Allowance for patent protection of...

Amarin (AMRN +1.2%) says the USPTO has granted a Notice of Allowance for patent protection of its Vascepa, a prescription grade omega-3 fatty acid that can help reduce triglyceride levels in adults. The issued patent would have a term that expires no earlier than in 2030.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs